NB527266
CEACAM1/CD66a Antibody (labetuzumab) [Janelia Fluor™ 669], Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB527266-Each-of-1 | In Stock | ₹ 33,747.02 |
NB527266 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 33,747.02
GST (18%): ₹ 6,074.464
Total Price: ₹ 39,821.484
Antigen
CEACAM1/CD66a
Classification
Monoclonal
Conjugate
Janelia Fluor 669
Gene Alias
antigen CD66, BGP-1, BGP1BGPBiliary glycoprotein 1, BGPI, biliary glycoprotein adhesion molecule, carcinoembryonic antigen-related cell adhesion molecule 1, carcinoembryonic antigen-related cell adhesion molecule 1 (biliaryglycoprotein), CD66a, CD66a antigen
Immunogen
CEACAM5/ CEA/ CD66e
Quantity
0.1 mL
Research Discipline
Apoptosis, Cancer
Gene ID (Entrez)
634
Content And Storage
Store at 4°C in the dark.
Isotype
IgG1
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
labetuzumab
Formulation
50mM Sodium Borate
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Related Products
Description
- CEACAM1/CD66a Monoclonal antibody specifically detects CEACAM1/CD66a in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay